1.4212

385.40% 1.1266

Hcw Biologics Inc (HCWB)

Overview News Price History Financials Discussions Forecast

Hcw Biologics Inc stock is traded at $1.4212, with a volume of 487.46M. It is up +385.40% in the last 24 hours and up +174.95% over the past month. HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Previous Close:

$0.2946

Open:

$0.9105

24h Volume:

487.46M

Relative Volume:

68.82

Market Cap:

$52.19M

Revenue:

$3.92M

Net Income/Loss:

$-38.37M

P/E Ratio:

-2.7331

EPS:

-0.52

Net Cash Flow:

$-22.41M

1W Performance:

+296.89%

1M Performance:

+174.95%

6M Performance:

+30.00%

1Y Performance:

+30.59%

1-Day Range:

$0.85

$2.52

1-Week Range:

$0.2761

$2.52

52-Week Range:

$0.2761

$2.52

Hcw Biologics Inc Stock (HCWB) Company Profile

Name

Hcw Biologics Inc

Sector

Healthcare (1200)

Industry

Biotechnology (682)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

HCWB's Discussions on Twitter

Compare HCWB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HCWB	1.4223	52.19M	3.92M	-38.37M	-22.41M	-0.52
VRTX	467.43	119.83B	10.63B	-479.80M	-1.35B	13.33
REGN	760.66	83.28B	13.85B	4.65B	3.32B	35.06
ARGX	565.62	33.74B	1.86B	-40.29M	-1.28B	-4.16
ALNY	230.53	30.38B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.40	24.08B	3.30B	-501.07M	1.03B	11.54

Hcw Biologics Inc Stock (HCWB) Latest News

02:08 AM

Owning 44% shares,institutional owners seem interested in Jamieson Wellness Inc. (TSE:JWEL), - Yahoo Finance

02:08 AM

01:07 AM

HCW Biologics Shares Surge on License Agreement - MarketWatch

01:07 AM

12:47 PM

Broward pharma developer inks $7 million deal with Chinese firm - The Business Journals

12:47 PM

12:29 PM

Enphase Energy Powers Up with US-Made IQ Batteries: Unlocking Bonus Tax Credits - AOL

12:29 PM

12:21 PM

California logistics company files for Chapter 11 - Yahoo Finance

12:21 PM

12:20 PM

Crude Oil Rises Sharply; US Homebuilder Sentiment Surges In November - Benzinga

12:20 PM

12:15 PM

Spirit Airlines Declares Bankruptcy After Failed Merger and Rising Costs - Yahoo Finance

12:15 PM

12:12 PM

Stock Market News: HCW Biologics increase by 521.18% while CareMax drops by 49.20% during mid day trading - Business Upturn

12:12 PM

11:14 AM

Stock market today: CareMax(−41.19%), HCW Biologics(+209.06%) among the most volatile stocks in early trading - Business Upturn

09:51 AM

07:21 AM

Kandi Technologies Reports Third Quarter 2024 Financial Results - The Manila Times

07:21 AM

07:12 AM

HCW Biologics jumps on license agreement for immunotherapeutic product candidate - Seeking Alpha

07:12 AM

07:02 AM

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate - GlobeNewswire

07:02 AM

07:00 AM

Can Top Artifical Intelligence (AI) Stock Nvidia Crush the Market in 2025? - AOL

07:00 AM

Nov 17, 2024

HCW Biologics Third Quarter 2024 Earnings: US$0.10 loss per share (vs US$0.14 loss in 3Q 2023) - Simply Wall St

Nov 17, 2024

Nov 14, 2024